{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T15:35:50Z","timestamp":1781105750984,"version":"3.54.1"},"reference-count":8,"publisher":"Japanese Society for Pediatric Endocrinology","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Pediatr Endocrinol"],"published-print":{"date-parts":[[2017]]},"DOI":"10.1297\/cpe.26.165","type":"journal-article","created":{"date-parts":[[2017,7,26]],"date-time":"2017-07-26T18:14:01Z","timestamp":1501092841000},"page":"165-169","source":"Crossref","is-referenced-by-count":4,"title":["Sulfonylurea treatment in an infant with transient neonatal diabetes mellitus caused by an adenosine triphosphate binding cassette subfamily C member 8 gene mutation"],"prefix":"10.1297","volume":"26","author":[{"given":"Masayo","family":"Yamazaki","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Jichi Medical University, Tochigi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Sugie","sequence":"additional","affiliation":[{"name":"Faculty of Health and Medical Sciences, Tokoha University, Shizuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makiko","family":"Oguma","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Jichi Medical University, Tochigi, Japan"},{"name":"Department of Pediatrics, Japan Community Health care Organization Utsunomiya Hospital, Tochigi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tohru","family":"Yorifuji","sequence":"additional","affiliation":[{"name":"Department of Pediatric Endocrinology and Metabolism, Children\u2019s Medical Center, Osaka City General Hospital, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiro","family":"Tajima","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Jichi Medical University, Tochigi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Yamagata","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Jichi Medical University, Tochigi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"125","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Aguilar-Bryan, L, Bryan, J. Neonatal diabetes mellitus. Endocr Rev 2008;29: 265\u201391.","DOI":"10.1210\/er.2007-0029"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Greeley, SAW, Tucker, SE, Naylor, RN, Bell, GI, Philipson, LH. Neonatal diabetes mellitus: a model for personalized medicine. Trends Endocrinol Metab 2010;21: 464\u201372.","DOI":"10.1016\/j.tem.2010.03.004"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Suzuki, S, Koga, M, Amamiya, S, Nakao, A, Wada, K, Okuhara, K, et al. Glycated albumin but not HbA1c reflects glycaemic control in patients with neonatal diabetes mellitus. Diabetologia 2011;54: 2247\u201353.","DOI":"10.1007\/s00125-011-2211-8"},{"key":"4","unstructured":"4. Hattersley, A. Transferring patients with diabetes due to a Kir6.2 mutation from insulin to sulphonylureas in patients who are aged under 1 year. http:\/\/www.diabetesgenes.org\/content\/transferring-patients-diabetes-due-kir62-mutation-insulin-sulphonylureas."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Rafiq, M, Flanagan, SE, Patch, AM, Shields, BM, Ellard, S, Hattersley, AT, Neonatal Diabetes International Collaborative Group. Effective treatment with oral sulfonylureas in patients with diabetes due to sulfonylurea receptor 1 (SUR1) mutations. Diabetes Care 2008;31: 204\u20139.","DOI":"10.2337\/dc07-1785"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Hashimoto, Y, Dateki, S, Hirose, M, Satomura, K, Sawada, H, Mizuno, H, et al. Molecular and clinical features of K<sub>ATP<\/sub> -channel neonatal diabetes mellitus in Japan. Pediatr Diabetes 2016; [Epub ahead of print].","DOI":"10.1111\/pedi.12447"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Remedi, MS, Agapova, SE, Vyas, AK, Hruz, PW, Nichols, CG. Acute sulfonylurea therapy at disease onset can cause permanent remission of K<sub>ATP<\/sub>-induced diabetes. Diabetes 2011;60: 2515\u201322.","DOI":"10.2337\/db11-0538"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Villareal, DT, Koster, JC, Robertson, H, Akrouh, A, Miyake, K, Bell, GI, et al. Kir6.2 variant E23K increases ATP-sensitive K<sup>+<\/sup> channel activity and is associated with impaired insulin release and enhanced insulin sensitivity in adults with normal glucose tolerance. Diabetes 2009;58: 1869\u201378.","DOI":"10.2337\/db09-0025"}],"container-title":["Clinical Pediatric Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/cpe\/26\/3\/26_2016-0034\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T13:17:39Z","timestamp":1569935859000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/cpe\/26\/3\/26_2016-0034\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":8,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1297\/cpe.26.165","relation":{},"ISSN":["0918-5739","1347-7358"],"issn-type":[{"value":"0918-5739","type":"print"},{"value":"1347-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}